These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22687143)

  • 41. Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study.
    Tschanz JT; Piercy K; Corcoran CD; Fauth E; Norton MC; Rabins PV; Tschanz BT; Deberard MS; Snyder C; Smith C; Lee L; Lyketsos CG
    Am J Geriatr Psychiatry; 2013 Jan; 21(1):57-66. PubMed ID: 23290203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores.
    Williams MM; Storandt M; Roe CM; Morris JC
    Alzheimers Dement; 2013 Feb; 9(1 Suppl):S39-44. PubMed ID: 22858530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
    Doraiswamy PM; Sperling RA; Coleman RE; Johnson KA; Reiman EM; Davis MD; Grundman M; Sabbagh MN; Sadowsky CH; Fleisher AS; Carpenter A; Clark CM; Joshi AD; Mintun MA; Skovronsky DM; Pontecorvo MJ;
    Neurology; 2012 Oct; 79(16):1636-44. PubMed ID: 22786606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal Sensitivity of Alzheimer's Disease Severity Staging.
    Benoit JS; Chan W; Piller L; Doody R
    Am J Alzheimers Dis Other Demen; 2020; 35():1533317520918719. PubMed ID: 32573256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument.
    Amariglio RE; Donohue MC; Marshall GA; Rentz DM; Salmon DP; Ferris SH; Karantzoulis S; Aisen PS; Sperling RA;
    JAMA Neurol; 2015 Apr; 72(4):446-54. PubMed ID: 25706191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.
    Cortes F; Nourhashémi F; Guérin O; Cantet C; Gillette-Guyonnet S; Andrieu S; Ousset PJ; Vellas B;
    Alzheimers Dement; 2008 Jan; 4(1):22-9. PubMed ID: 18631947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occupational exposure to pesticides increases the risk of incident AD: the Cache County study.
    Hayden KM; Norton MC; Darcey D; Ostbye T; Zandi PP; Breitner JC; Welsh-Bohmer KA;
    Neurology; 2010 May; 74(19):1524-30. PubMed ID: 20458069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial.
    Rosenberg A; Solomon A; Soininen H; Visser PJ; Blennow K; Hartmann T; Kivipelto M;
    Alzheimers Res Ther; 2021 Mar; 13(1):64. PubMed ID: 33766132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease.
    Lee WJ; Liao YC; Wang YF; Lin YS; Wang SJ; Fuh JL
    J Am Geriatr Soc; 2020 Jan; 68(1):129-136. PubMed ID: 31587263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C; Wallin ÅK
    Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia.
    Lyketsos CG; Galik E; Steele C; Steinberg M; Rosenblatt A; Warren A; Sheppard JM; Baker A; Brandt J
    J Am Geriatr Soc; 1999 Apr; 47(4):487-91. PubMed ID: 10203127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of progression to severe Alzheimer's disease in an incidence sample.
    Rabins PV; Schwartz S; Black BS; Corcoran C; Fauth E; Mielke M; Christensen J; Lyketsos C; Tschanz J
    Alzheimers Dement; 2013 Mar; 9(2):204-7. PubMed ID: 23123228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Physical Activity on the Progression of Alzheimer's Disease: The Clinical Research Center for Dementia of South Korea Study.
    Minn YK; Choi SH; Suh YJ; Jeong JH; Kim EJ; Kim JH; Park KW; Park MH; Youn YC; Yoon B; Choi SJ; Oh YK; Yoon SJ
    J Alzheimers Dis; 2018; 66(1):249-261. PubMed ID: 30282355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.
    Bleckwenn M; Kleineidam L; Wagner M; Jessen F; Weyerer S; Werle J; Wiese B; Lühmann D; Posselt T; König HH; Brettschneider C; Mösch E; Weeg D; Fuchs A; Pentzek M; Luck T; Riedel-Heller SG; Maier W; Scherer M
    Br J Gen Pract; 2017 Feb; 67(655):e111-e117. PubMed ID: 27993897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of APOE haplotypes and measures of cardiovascular risk over gender-dependent cognitive and functional changes in one year in Alzheimer's disease.
    de Oliveira FF; Pereira FV; Pivi GAK; Smith MC; Bertolucci PHF
    Int J Neurosci; 2018 May; 128(5):472-476. PubMed ID: 29064737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.